[Biologics Biosimilars Congress 2017] Phenotypic Human Primary Cell-Based Tumor Microenvironment Models for Evaluation of Drug Combinations for Immune Oncology

[Biologics Biosimilars Congress 2017] Phenotypic Human Primary Cell-Based Tumor Microenvironment Models for Evaluation of Drug Combinations for Immune Oncology
Version:
030617

File Name/Number:
2017 Biologics & Biosimilars Congress

Year:
2017

We have developed complex in vitro co-cultures of human primary cells to model disease states in a standardized format to enable phenotypic drug screening.